According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are HK$38.05 Million. In 2023 the company made an earning of HK$91.46 Million, an increase over its 2022 earnings that were of -HK$92.35 Million. The earnings displayed on this page is the company's Pretax Income.